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Hematuria Awareness for 
Patients
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Community Health Centers of Burlington (CHCB)
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1) Problem Identification and Description of 
Need
▪ In the United States, cancer of the urinary bladder is the most common
malignancy of the urinary system, representing an estimated incidence of 76,960
out of 142,190 (54.1%) new cases of urinary system malignancies and 16,390 out
of 31,540 (60.0%) of deaths from urinary system malignancies in 2016 [1].
▪ Accordingly, urinary bladder cancer is estimated to comprise 76,960 out of the
1,685,210 (4.57%) new cancer cases diagnosed in the US in 2016 and 16,390 out of
the 595,690 (2.75%) deaths from cancer in the US in 2016 [1].
▪ In Vermont, the prevalence of bladder cancer exceeds that of the nation: 220 new
cases of urinary bladder cancer out of 4,050 new cancer cases in 2016 (5.43%) [1].
2a) Problem Identification and Description of Need
cont’d.
▪ The importance of presenting to medical
attention as early as possible in the
course of bladder cancer can not be
understated.
▪ The marked discrepancy between the
five year survival for carcinoma in situ
(96%), localized cancer (70%), regionally
metastatic (34%), and distant metastatic
(5%) represents an exceptional
opportunity for improving cure rates by
way of strengthening patients’
motivation to present to their PCP for
evaluation.
*The proportion of cases of carcinoma in situ of the urinary
bladder is 51% in all races combined, 52% in whites, and 40%
in blacks.
†The survival rate for carcinoma in situ of the urinary bladder
is 96% in all races combined, 96% in whites, and 90% in blacks.
Adapted from: Siegel, R. L., Miller, K. D., & Jemal, A. (2016).
Cancer statistics, 2016. CA Cancer J Clin, 66(1), 7-30.
doi:10.3322/caac.21332
2b) Problem Identification and Description of Need
cont’d.
▪ The differential for gross hematuria is vast, often necessitating an extensive work-up despite
meticulous history-taking.
▪ Several prospective studies of individuals evaluated for gross hematuria have found the
prevalence of bladder cancer to range from 10 to 20 percent [2-4].
▪ The spectrum of bladder cancer includes non-muscle-invasive (superficial), muscle-invasive, and
metastatic disease, each with its own clinical behavior, biology, prognosis, and treatment [5].
▪ Although in most cases of reported gross hematuria the etiology is found to be non-malignant
(ex. nephritis, admixture of menstrual blood, urethritis, myoglobinuria, etc.) or no cause can be
identified, any delay in diagnosing urothelial or squamous cell carcinoma of the bladder
represents an immense risk for further progression, invasion, and/or metastasis of what may
initially be a readily curable in situ carcinoma.
▪ For these reasons, the participants in this project believe that the health of individuals in the
greater Burlington community stands to benefit significantly from any intervention that would
promote the earliest possible reporting of gross hematuria that may be a sentinel event in the
progression of bladder cancer.
3a) Public Health Cost
▪ Several internet companies now operate sites that let consumers around the United
States search for estimates of typical costs in their area.
▪ healthcarebluebook.com is one such service, started in 2007, offers an estimate of a
“fair price” that consumers can expect to pay in their area.
▪ From healthcarebluebook.com: “What is the fair price?”
▪ “The Fair Price is the reasonable amount you should pay for a medical service. It’s
calculated from a nationwide database of medical payment data and customized to your
geographic area.” [6]
▪ While this service offers little explanation in the way of which databases it uses or
any significant explanation of its methodology, it is a suitable starting point for
comparing medical expenses in a given area.
▪ For this project, it can be used to compare treatments for bladder cancer depending
on the progression of the disease, which as mentioned before is highly dependent
on the time between the onset of symptoms and presentation for evaluation.
3b) Public Health Cost cont’d.
3c) Public Health Cost cont’d.
4) Community Perspective and Project Support
Kim Anderson (August 4, 2016)
Associate Director, Community Relations & Development –
Community Health Centers of Burlington
 CHCB maintains robust advertising efforts throughout
Chittenden and Grand Isle counties and on the internet.
 Examples: outside of CCTA buses, local newspapers (Burlington
Free Press, North Ave news), several blogs
 Anecdotal evidence that finding a primary care provider in
the Burlington area is notoriously difficult and that CHCB
is one of a small number of centers accepting new patients.
 The aim of this project to inform the public that hematuria is a
symptom that should not be ignored would also have the
additional effect of letting the public know that CHCB is
accepting new patients
 The proposed awareness project could be easily adapted to
a variety of print, electronic, and public space media forms.
 This project’s combination of a simple message, bright
colors, and representative creative photography is unlikely
to be ignored.
Scott Perrapato, DO (July 28, 2016)
Director, Genitourinary Oncology Trans-Disciplinary Team –
University of Vermont Medical Center
Associate Professor, Urology – University of Vermont College of 
Medicine
 Delay in reporting symptoms is plays a major role in 
unchecked progression of not only bladder cancer, but 
most genitourinary malignancies
 The most common rationalization for ignoring 
hematuria is that because it is sporadic at its onset it 
can be ignored
 Many patients ignore this sign until gross hematuria is 
present at each voiding or other symptoms (pain, 
voiding symptoms, constitutional symptoms) 
accompany it
 Progression of hematuria from sporadic to persistent 
almost invariably represents further invasion of the 
disease
 Increasing awareness in patients who have 
undiagnosed bladder cancers that gross hematuria 
should never be ignored will prompt them to report 
this symptom earlier and allow them to begin 
treatment at a less advanced stage in their disease
5) Intervention and Methodology
▪ The goal of the intervention was to develop a simple advertisement for all members of the public
that could be easily adapted to presentation in many spaces and media forms.
▪ Bright colors and poignant, short phrases are expected to attract the greatest attention.
▪ So as to avoid any stigma, cultural or otherwise, toward a public discussion of urine, including
colorful candies as the backdrop of as serious of a topic as this has been thought to have a
destigmatizing and calming effect.
▪ The m&m candies were purchased at Party City in South Burlington, VT. The photography was
completed by DA using a Nikon d5200 dSLR camera. Image editing was done in Adobe Photoshop
Lightroom 5.7.1 and Adobe Photoshop CC. Translation was completed with Google Translate.
▪ The merits of including the CHCB logo and contact info were discussed with Kim Anderson and it
was agreed that this decision is appropriate and impactful (see “Community Perspective and Project
Support”)
▪ Furthermore, as CHCB is well-tailored to providing services to non-English speaking members of
the community two additional considerations were included
▪ During the 5-weeks I spent at CHCB, I met with Nepali-speaking patients daily, Somali-speaking patients at
least weekly, and French and Arabic speaking patients on multiple occasions
▪ Translating the messages included in the advertisement would allow this advertisement to be impactful if
displayed in the cultural/religious centers and publications of these communities
6a) Results
6b) Results cont’d.
7) Evaluation of Effectiveness and Limitations 
▪ As this study represents an intervention that is yet to be implemented, it is necessary to
consider a strategy for follow-up on its effectiveness.
▪ One such model that could be applied would examine retrospective data on patients
presenting with gross hematuria prior to 2016 and prospective data on patients presenting
with gross hematuria after 2016. Significant outcomes to examine:
▪ number of patients who presented with this symptom during equivalent spans of time at CHCB
and/or other area primary care practices
▪ differences in urinalysis findings from these patients
▪ number of referrals for cystoscopy
▪ Most importantly: changes in frequency at which bladder cancers of different stages are discovered.
▪ Limitations:
▪ While hematuria is the most common initial symptom of this disease, it is not the only initial symptom
and as such this intervention does not address patients whose initial sign may be pain or voiding
symptoms or symptoms as a result of metastatic progression
▪ Patients who are unable to read any of the languages into which the advertisement was translated will
be unable to benefit from it unless informed by another person
▪ Some patients may continue to rationalize or minimize the need for evaluation despite this intervention
8) Future Directions
▪ Follow-up on changes in trends of presentation for gross hematuria, urinalysis 
results, urology/cystoscopy referrals, staging of bladder cancer in the greater 
Burlington area, as described in “Evaluation of Effectiveness and Limitations.”
▪ In the event that a significant improvement in bladder cancer outcomes is 
observed, while controlling for advances in therapy and access to care, this 
model of health awareness through creative photography and poignant 
advertisement placement may be adapted for symptoms of or screening tests for 
other cancers.
▪ Initial considerations for a similar campaign: 
1) colorectal cancer screening or symptoms
2) lung cancer screening or symptoms
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